These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25078395)

  • 1. Does the interferon-lambda rather than the interferon-alpha pathway determine the outcome of hepatitis C virus infection?
    Mihm S; Spengler U; Amanzada A; Ramadori G
    Hepatology; 2014 Oct; 60(4):1437-9. PubMed ID: 25078395
    [No Abstract]   [Full Text] [Related]  

  • 2. IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies.
    Duong FH; Trincucci G; Boldanova T; Calabrese D; Campana B; Krol I; Durand SC; Heydmann L; Zeisel MB; Baumert TF; Heim MH
    J Exp Med; 2014 May; 211(5):857-68. PubMed ID: 24752298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of type I interferon receptor in liver and peripheral blood mononuclear cells in chronic hepatitis C patients.
    Yamaguchi Y; Hino K; Fujiwara D; Ren F; Katoh Y; Satoh Y; Okita K
    Dig Dis Sci; 2002 Jul; 47(7):1611-7. PubMed ID: 12141824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Type I IFN receptor].
    Hino K; Yamaguchi Y; Okita K
    Nihon Rinsho; 2001 Jul; 59(7):1351-5. PubMed ID: 11494550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.
    Abbate I; Romano M; Longo R; Cappiello G; Lo Iacono O; Di Marco V; Paparella C; Spano A; Capobianchi MR
    J Med Virol; 2003 Aug; 70(4):581-7. PubMed ID: 12794720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
    Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
    Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization.
    Patzwahl R; Meier V; Ramadori G; Mihm S
    J Virol; 2001 Feb; 75(3):1332-8. PubMed ID: 11152506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic interferon receptor mRNA expression: clinical relevance and its relationship with effectiveness of interferon plus ribavirin therapy in patients with genotype 1b hepatitis C virus infection.
    Lee CM; Kee KM; Hung CH; Eng HL; Chang CH; Huang CM; Wang JH; Hu TH; Lu SN; Changchien CS; Chen WJ
    Antivir Ther; 2006; 11(1):17-23. PubMed ID: 16518956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Host factors determining the outcome of IFN treatment for chronic hepatitis C].
    Kiyosawa K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):481-4. PubMed ID: 15359845
    [No Abstract]   [Full Text] [Related]  

  • 10. Intrahepatic mRNA expression of interferon-inducible antiviral genes in liver diseases: dsRNA-dependent protein kinase overexpression and RNase L inhibitor suppression in chronic hepatitis C.
    Yu SH; Nagayama K; Enomoto N; Izumi N; Marumo F; Sato C
    Hepatology; 2000 Nov; 32(5):1089-95. PubMed ID: 11050060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferons and their receptors in birds: a comparison of gene structure, phylogenetic analysis, and cross modulation.
    Zhou H; Chen S; Wang M; Cheng A
    Int J Mol Sci; 2014 Nov; 15(11):21045-68. PubMed ID: 25405736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon signaling in the liver during hepatitis C virus infection.
    Makowska Z; Heim MH
    Cytokine; 2012 Sep; 59(3):460-6. PubMed ID: 22749235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?
    Yang DR; Zhu HZ
    World J Gastroenterol; 2015 Apr; 21(13):3786-800. PubMed ID: 25852264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catabolism of interferons.
    Bocci V
    Surv Immunol Res; 1982; 1(2):137-43. PubMed ID: 6195713
    [No Abstract]   [Full Text] [Related]  

  • 15. Early events in signalling by interferons.
    Pellegrini S; Schindler C
    Trends Biochem Sci; 1993 Sep; 18(9):338-42. PubMed ID: 7694399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferons and their antitumor properties.
    Platanias LC
    J Interferon Cytokine Res; 2013 Apr; 33(4):143-4. PubMed ID: 23570379
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of interferon action.
    Leaman DW
    Prog Mol Subcell Biol; 1998; 20():101-42. PubMed ID: 9928528
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of GBV-C infection on the endogenous activation of the IFN system in HIV-1 co-infected patients.
    Capobianchi MR; Lalle E; Martini F; Poccia F; D'Offizi G; Antonucci G; Abbate I; Dianzani F
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):3-8. PubMed ID: 16914092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients.
    Lau DT; Fish PM; Sinha M; Owen DM; Lemon SM; Gale M
    Hepatology; 2008 Mar; 47(3):799-809. PubMed ID: 18203148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection.
    Sung PS; Shin EC; Yoon SK
    Int J Mol Sci; 2015 Oct; 16(10):23683-94. PubMed ID: 26457705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.